🇺🇸
United States · US · US:0069-0106_d7eb51c8-fe18-46f2-8d97-eaa343ec8821
ELELYSO
UNIISPLATC A16AB11
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerPfizer Laboratories Div Pfizer Inc
CountryUS (United States)
ATC codeA16AB11
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1100690106011 VIAL, GLASS in 1 CARTON (0069-0106-01) / 5 mL in 1 VIAL, GLASS
Annotations
UNII (FDA Substance ID)
0R4NLX88O4
TALIGLUCERASE ALFA
RxCUI 1291609
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "0R4NLX88O4",
"rxcui": "1291609",
"inchikey": null,
"display_name": "TALIGLUCERASE ALFA",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"spl_meta": {
"fa3cbd5d-677c-4b19-9032-d9182cb69a83": {
"match": "brand_token",
"title": "ELELYSO (TALIGLUCERASE ALFA) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC]",
"spl_version": "31",
"published_date": "2025-12-31"
}
},
"productid": "0069-0106_d7eb51c8-fe18-46f2-8d97-eaa343ec8821",
"productndc": "0069-0106",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "TALIGLUCERASE ALFA",
"proprietary_name": "ELELYSO",
"active_ingred_unit": "U/5mL",
"application_number": "BLA022458",
"marketing_category": "BLA",
"nonproprietary_name": "Taliglucerase alfa",
"start_marketing_date": "20120501",
"active_numerator_strength": "200"
}Related drugs
Other records sharing ATC code A16AB11.
Access this data programmatically
Query ELELYSO and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.